End-of-day quote
Other stock markets
|
||
- USD | - |
05-08 | Earnings Flash (INVA) INNOVIVA Posts Q1 Revenue $77.5M | MT |
05-08 | Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 308M 24.43B | Sales 2025 * | 334M 26.54B | Capitalization | 1.01B 80.3B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 4.02 x |
Net Debt 2024 * | 224M 17.81B | Net Debt 2025 * | 145M 11.5B | EV / Sales 2025 * | 3.46 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.49% |
Latest transcript on Theravance Inc
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 19/05/20 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 20/08/23 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 30/09/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 11/02/18 | |
Director/Board Member | 53 | 31/12/22 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 11/02/18 |
1st Jan change | Capi. | |
---|---|---|
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |